Literature DB >> 12237166

Differential regulation of cardiac protein kinase C isozyme expression after aortic banding in rat.

Martin U Braun1, Paul LaRosée, Steffen Schön, Mathias M Borst, Ruth H Strasser.   

Abstract

OBJECTIVE: Protein kinase C (PKC) plays a key role in myocardial hypertrophy. To evaluate whether its isoforms are expressed differentially during gradual development of pressure-overload-induced cardiac hypertrophy, banding of the ascending aorta was used as an experimental model of left ventricular hypertrophy.
METHODS: One, 7 and 30 days after sham operation or aortic banding in male Wistar rats, the PKC activity and the expression of the cardiac PKC isozymes (PKC-alpha, -delta, - epsilon and -zeta), both at the protein and the mRNA level, were determined in the left and right ventricle.
RESULTS: Left ventricular hypertrophy developed rapidly as early as 1 day after aortic banding followed by further progression at day 7 and day 30. This was paralleled by an increased total PKC enzyme activity in the cytosol fraction and a selectively enhanced protein expression of PKC-delta (day 7, 267+/-18%; day 30, 289+/-12%) and PKC-alpha (day 7, 212+/-20%; day 30, 193+/-14%). The protein amount of PKC- epsilon was not changed in either group. This differential protein expression was associated with a significant increase of the absolute mRNA levels for PKC-delta and PKC-alpha up to 202+/-20% (day 30) and 177+/-17% (day 30), whereas significant alterations in the PKC- epsilon mRNA levels were not detected. A selective upregulation of PKC-alpha and PKC-delta, both on the protein and on the mRNA level, was also noted in the right ventricle during the development of right ventricular hypertrophy, suggesting an adaptive response following elevated left ventricular enddiastolic pressure after long-term aortic banding for 30 days.
CONCLUSIONS: This study characterizes in the right and left ventricle a differential regulation of the dominant PKC isozymes in pressure-overload cardiac hypertrophy both at the protein and the mRNA level.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12237166     DOI: 10.1016/s0008-6363(02)00511-4

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  8 in total

1.  Disruption of adenylyl cyclase type V does not rescue the phenotype of cardiac-specific overexpression of Galphaq protein-induced cardiomyopathy.

Authors:  Valeriy Timofeyev; Cliff A Porter; Dipika Tuteja; Hong Qiu; Ning Li; Tong Tang; Anil Singapuri; Pyung-Lim Han; Javier E Lopez; H Kirk Hammond; Nipavan Chiamvimonvat
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-08-13       Impact factor: 4.733

Review 2.  Protein kinase Cα as a heart failure therapeutic target.

Authors:  Qinghang Liu; Jeffery D Molkentin
Journal:  J Mol Cell Cardiol       Date:  2010-10-16       Impact factor: 5.000

3.  Regulation of protein kinase C isozymes in volume overload cardiac hypertrophy.

Authors:  Martin U Braun; Paul LaRosée; Gregor Simonis; Mathias M Borst; Ruth H Strasser
Journal:  Mol Cell Biochem       Date:  2004-07       Impact factor: 3.396

4.  Selective deletion of long but not short Cypher isoforms leads to late-onset dilated cardiomyopathy.

Authors:  Hongqiang Cheng; Ming Zheng; Angela K Peter; Kensuke Kimura; Xiaodong Li; Kunfu Ouyang; Tao Shen; Li Cui; Derk Frank; Nancy D Dalton; Yusu Gu; Norbert Frey; Kirk L Peterson; Sylvia M Evans; Kirk U Knowlton; Farah Sheikh; Ju Chen
Journal:  Hum Mol Genet       Date:  2011-02-08       Impact factor: 6.150

5.  Protein kinase C in the human heart: differential regulation of the isoforms in aortic stenosis or dilated cardiomyopathy.

Authors:  Gregor Simonis; Steffen K Briem; Steffen P Schoen; Manja Bock; Rainer Marquetant; Ruth H Strasser
Journal:  Mol Cell Biochem       Date:  2007-06-27       Impact factor: 3.396

6.  Role of protein kinase C-delta in angiotensin II induced cardiac fibrosis.

Authors:  Vishnu Chintalgattu; Laxmansa C Katwa
Journal:  Biochem Biophys Res Commun       Date:  2009-06-18       Impact factor: 3.575

Review 7.  Role and Mechanism of PKC-δ for Cardiovascular Disease: Current Status and Perspective.

Authors:  Li-Na Miao; Deng Pan; Junhe Shi; Jian-Peng Du; Peng-Fei Chen; Jie Gao; Yanqiao Yu; Da-Zhuo Shi; Ming Guo
Journal:  Front Cardiovasc Med       Date:  2022-02-15

Review 8.  Protein kinase C in heart failure: a therapeutic target?

Authors:  Suresh Selvaraj Palaniyandi; Lihan Sun; Julio Cesar Batista Ferreira; Daria Mochly-Rosen
Journal:  Cardiovasc Res       Date:  2009-01-24       Impact factor: 13.081

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.